Everest Organics Q1 Results: Net profit falls 20% YoY to ₹111.34 lakh
Everest Organics posted a net profit of ₹111.34 lakh in Q1FY27, down 20.8% YoY, as revenue slipped 10% to ₹4,843.06 lakh. Pre-tax profits declined more sharply at 29.4%, signaling margin compression. Reserves grew to ₹6,688.11 lakh, while equity capital remained stable at ₹971.05 lakh.

*this image is generated using AI for illustrative purposes only.
Everest Organics reported a net profit of ₹111.34 lakh for the quarter ended June 30, 2026, marking a decline from the ₹140.52 lakh recorded in the corresponding period of FY25. Revenue from operations for Q1FY27 stood at ₹4,843.06 lakh, compared to ₹5,381.32 lakh in Q1FY25.
The company’s net profit before tax (PBT) decreased to ₹152.84 lakh in the current quarter, down from ₹216.43 lakh a year ago. Earnings per share (EPS), both basic and diluted, fell to ₹1.15 per share, lower than the ₹1.45 reported in Q1FY25.
Financial Performance
The Board of Directors approved the unaudited standalone financial results at a meeting held on August 14, 2026. The results have been reviewed by the Audit Committee and are subject to a limited review report by the auditors.
| Metric: | Q1FY27 | Q1FY26 | Change |
|---|---|---|---|
| Revenue from Operations: | ₹4,843.06 lakh | ₹5,381.32 lakh | -10.0% |
| Net Profit Before Tax: | ₹152.84 lakh | ₹216.43 lakh | -29.4% |
| Net Profit After Tax: | ₹111.34 lakh | ₹140.52 lakh | -20.8% |
| EPS (Basic/Diluted): | ₹1.15 | ₹1.45 | -20.7% |
Balance Sheet Position
As of June 30, 2026, Everest Organics’ reserves increased to ₹6,688.11 lakh, up from ₹6,164.15 lakh in the same period last year. Equity share capital remained unchanged at ₹971.05 lakh. Total comprehensive income attributable to owners was ₹111.34 lakh, consistent with the net profit for the period.
What the Numbers Show
The divergence between revenue and profit declines highlights margin pressure during the quarter. While revenue contracted by approximately 10%, pre-tax profits fell nearly 30%, indicating that cost structures did not adjust proportionately to the lower top-line growth. This compression in operating efficiency is reflected in the wider gap between the PBT and PAT figures compared to the prior year.
Historical Stock Returns for Everest Organics
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.19% | -3.29% | -12.27% | -12.88% | -17.02% | -4.28% |
What specific cost drivers contributed to the disproportionate 29.4% drop in PBT compared to the 10% revenue decline, and are these costs structural or temporary?
How does Everest Organics plan to address the margin compression observed in Q1FY27 to restore profitability growth in subsequent quarters?
Are there any strategic initiatives or product mix changes planned to reverse the revenue contraction trend seen in the quarter ended June 30, 2026?


































